... Cephalon, Inc), topiramate (Topamax, Ortho-McNeil Pharmaceutical, Inc), valproate (Depakote/Depakote ER, Depakene, and Depacon, Abbott Laboratories), ...
... Topiramate (marketed as Topamax), Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) and Zonisamide (marketed as Zonegran). ...
... Topiramate (marketed as Topamax), Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) and Zonisamide (marketed as Zonegran). ...
... Zydus to prevent them from selling generic versions of the epilepsy drug Depakote ER in the US Sandoz, the world's second-largest generic drug-maker, ...
Novartis AG (NOVN VX): Abbott Laboratories sued Novartis ag's Sandoz to prevent it from selling generic versions of the epilepsy drug Depakote ER in the US ...
... the company expects to meet Wall Street estimates even if its Xience stent V is delayed and competition for its migraine drug Depakote ER increases. ...
... the company expects to meet Wall Street estimates even if its Xience stent V is delayed and competition for its migraine drug Depakote ER increases. ...
... the company expects to meet Wall Street estimates even if its Xience stent V is delayed and competition for its migraine drug Depakote ER increases. ...
Stavzor(TM) will be a branded product; it is not expected to be AB-rated to or generically substitutable for Depakote(R), nor will Depakote(R) or any ...
Half of the teenagers took Depakote, an antiseizure drug used to treat epilepsy and bipolar disorder in adults. The other half took Seroquel and Depakote. ...